3 companies unite to develop POC coronavirus serology test

LabPulse.com staff writers
Apr 16, 2020
2020 03 25 23 27 0591 Hands Shaking Deal 400

True Diagnostics, Infectolab, and Veravas have teamed up to develop and market a point-of-care (POC) rapid serology test for the novel coronavirus.

The VeraTest SARS-CoV-2 immunoglobulin A/immunoglobulin G (IgA/IgG) rapid test will determine whether antibodies against COVID-19 have been detected in a blood sample, with results available in fewer than 15 minutes, according to the companies.

The team effort combines the following:

  • True Diagnostics' TrueDx platform for POC diagnostics
  • Infectolab's COVID-19 serology testing services and infectious disease expertise
  • Veravas' VeraPrep clean and capture technologies

The test is designed to bind and detect antibodies specific to SARS-CoV-2 and remove cross-reacting antibodies to other types of coronaviruses, the companies said.

Latest in COVID-19
Fda Button Social
FDA grants full approval for antiviral pill to treat mild-to-moderate COVID-19 in adults
May 25, 2023
Covid 19 Global Financial Crisis Social
NIH-backed project develops scoring system for identifying long-COVID patients
May 25, 2023
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
May 11, 2023
Covid 19 Vaccine Distribution Transport Social
Medical records link vaccination against COVID-19 to reduced risk of non-respiratory symptoms
May 23, 2023
Related Stories
2020 04 29 20 30 6458 Medical Worker Blood Test 400
PCR
Rapid point-of-care COVID-19 test shows promise in clinical study
2017 01 30 15 46 05 570 Cdc Logo 400
COVID-19
CDC details new serology test for COVID-19
2020 04 16 18 56 8041 Virus Coronavirus Sars Co V 2 400
510(k)
NovaBay inks COVID-19 antibody test distribution deal
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in COVID-19
FDA grants full approval for antiviral pill to treat mild-to-moderate COVID-19 in adults
Paxlovid is the fourth drug — and first antiviral pill — approved by the FDA to treat COVID-19 in adults.
May 25, 2023
Fda Button Social
NIH-backed project develops scoring system for identifying long-COVID patients
While multiple earlier studies have assessed the effects of long COVID, previous efforts largely had retrospective designs, relied on electronic health record entries, and lacked an uninfected comparison group.
May 25, 2023
Covid 19 Global Financial Crisis Social
Domus Diagnostics gets $2.4M NIH grant to develop at-home molecular test
The award, granted as part of the NIH Rapid Acceleration of Diagnostics (RADx) Tech program, will support accelerated validation and scaling of a testing platform to prepare it for a clinical trial.
May 24, 2023
Money Bag Grant Award Social
Medical records link vaccination against COVID-19 to reduced risk of non-respiratory symptoms
An analysis, details of which were presented Tuesday at the ATS 2023 International Conference in Washington, DC, reviewed data from 63,454 patients who were treated in a University of California medical center for COVID-19.
May 23, 2023
Covid 19 Vaccine Distribution Transport Social
Antibody titer levels associated with protection against Omicron: Study
Immunoglobin G and neutralizing antibody titer levels were associated with protection against infection with the Omicron variant and against symptomatic disease.
May 23, 2023
Covid 19 Antibody Social
Masking and air cleaners reduced COVID-19 in two Swiss schools: Study
Face masks and portable air cleaners effectively reduced the spread of SARS-CoV-2, the virus that causes COVID-19, in two Swiss schools.
May 18, 2023
Children Facemask School Social
Masking should continue in healthcare settings, some experts say
Masking in healthcare settings should continue in order to optimize patient safety, recommend infectious disease experts in a commentary.
May 16, 2023
Doctors Masks Team Social
LumiraDx Q1 revenues drop 82% as its transition from non-COVID tests takes shape
In April, the company had announced a cost restructuring program involving a reduction of its global workforce by approximately 40%. It now expects to see the full impact of the restructuring activities during the third quarter.
May 16, 2023
Covid 19 Financial Chart Social
A closer look at long COVID symptoms
Intensively studied patients with persistent post-COVID neurological symptoms were found to have autonomic dysfunction and differences in their immune cell profiles.
May 10, 2023
Long Covid Word Cloud Social
FDA grants de novo request enabling the marketing of QuidelOrtho SARS-CoV-2 antibody tests
The tests are intended for prescription use only for the qualitative detection of IgG antibodies to SARS-CoV-2 to aid in identifying patients who have an adaptive immune response to SARS-CoV-2 from either a recent or prior infection.
May 10, 2023
Covid 19 Antibody Social
Siemens Healthineers Q2 diagnostics revenues drop 39% on decline in rapid antigen test sales
The firm is seeing a return to low- to mid-single digital revenue growth as swings in demand from COVID-19 testing to routine testing normalize, Sharon Bracken, its president of diagnostics, said in an interview.
May 10, 2023
Business Intelligence Social
Quest Diagnostics outlines changes to IVD landscape with end in sight for U.S. public health emergency
Some retail testing -- at pharmacies, for example -- may not be available and patient-initiated testing may not be covered, Quest said.
May 8, 2023
Sars Co V 2 Covid 19 Mask Pixabay Social
Page 1 of 32
Next Page